A detailed history of Amalgamated Bank transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 3,824 shares of MDXG stock, worth $35,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,824
Previous 3,824 -0.0%
Holding current value
$35,486
Previous $27,000 14.81%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$7.61 - $8.63 $46,382 - $52,599
-6,095 Reduced 61.45%
3,824 $29,000
Q4 2023

Feb 06, 2024

SELL
$5.7 - $9.14 $6,486 - $10,401
-1,138 Reduced 10.29%
9,919 $87,000
Q2 2023

Aug 11, 2023

SELL
$3.14 - $6.61 $1,563 - $3,291
-498 Reduced 4.31%
11,057 $73,000
Q1 2023

May 02, 2023

SELL
$2.97 - $4.81 $7,763 - $12,573
-2,614 Reduced 18.45%
11,555 $39,000
Q2 2022

Aug 15, 2022

SELL
$3.17 - $5.0 $7,459 - $11,765
-2,353 Reduced 14.24%
14,169 $49,000
Q1 2022

Jun 30, 2022

SELL
$4.27 - $6.27 $5,896 - $8,658
-1,381 Reduced 7.71%
16,522 $78,000
Q4 2021

Feb 15, 2022

SELL
$5.7 - $8.48 $1,487 - $2,213
-261 Reduced 1.44%
17,903 $108,000
Q3 2021

Oct 29, 2021

SELL
$5.52 - $15.83 $5,674 - $16,273
-1,028 Reduced 5.36%
18,164 $110,000
Q2 2021

Aug 16, 2021

BUY
$9.02 - $12.72 $173,111 - $244,122
19,192 New
19,192 $240,000
Q3 2018

Nov 14, 2018

SELL
$3.22 - $6.33 $54,025 - $106,204
-16,778 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$5.39 - $8.96 $9,960 - $16,558
1,848 Added 12.38%
16,778 $107,000
Q1 2018

May 22, 2018

SELL
$6.69 - $17.96 $1,612 - $4,328
-241 Reduced 1.59%
14,930 $104,000
Q4 2017

Feb 13, 2018

BUY
$10.87 - $13.9 $7,989 - $10,216
735 Added 5.09%
15,171 $191,000
Q3 2017

Nov 09, 2017

BUY
$11.86 - $17.34 $171,210 - $250,320
14,436
14,436 $171,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.